Scott A. Gangloff - Net Worth and Insider Trading
Scott A. Gangloff Net Worth
The estimated net worth of Scott A. Gangloff is at least $2,946 dollars as of 2024-09-20. Scott A. Gangloff is the SVP, Development & Mfrg of Outlook Therapeutics Inc and owns about 491 shares of Outlook Therapeutics Inc (OTLK) stock worth over $2,946. Details can be seen in Scott A. Gangloff's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Scott A. Gangloff has not made any transactions after 2016-11-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Scott A. Gangloff
Scott A. Gangloff Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Scott A. Gangloff owns 1 companies in total, including Outlook Therapeutics Inc (OTLK) .
Click here to see the complete history of Scott A. Gangloff’s form 4 insider trades.
Insider Ownership Summary of Scott A. Gangloff
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| OTLK | Outlook Therapeutics Inc | 2016-11-11 | SVP & Development & Mfrg |
Scott A. Gangloff Latest Holdings Summary
Scott A. Gangloff currently owns a total of 1 stock. Scott A. Gangloff owns 491 shares of Outlook Therapeutics Inc (OTLK) as of November 11, 2016, with a value of $2,946.
Latest Holdings of Scott A. Gangloff
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| OTLK | Outlook Therapeutics Inc | 2016-11-11 | 491 | 6.00 | 2,946 |
Holding Weightings of Scott A. Gangloff
Scott A. Gangloff Form 4 Trading Tracker
According to the SEC Form 4 filings, Scott A. Gangloff has made a total of 0 transactions in Outlook Therapeutics Inc (OTLK) over the past 5 years. The most-recent trade in Outlook Therapeutics Inc is the sale of 234 shares on November 11, 2016, which brought Scott A. Gangloff around $140,134.
Insider Trading History of Scott A. Gangloff
- 1
Scott A. Gangloff Trading Performance
Scott A. Gangloff Ownership Network
Scott A. Gangloff Owned Company Details
What does Outlook Therapeutics Inc do?
Who are the key executives at Outlook Therapeutics Inc?
Scott A. Gangloff is the SVP & Development & Mfrg of Outlook Therapeutics Inc. Other key executives at Outlook Therapeutics Inc include Chief Commercial Officer Jeff Evanson , Chief Operating Officer Terry Dagnon , and director & CEO and President Trenary C Russell Iii .
Outlook Therapeutics Inc (OTLK) Insider Trades Summary
Over the past 18 months, Scott A. Gangloff made no insider transaction in Outlook Therapeutics Inc (OTLK). Other recent insider transactions involving Outlook Therapeutics Inc (OTLK) include a net sale of 520,000 shares made by Terry Dagnon , a net purchase of 62,484 shares made by Jeff Evanson , and a net purchase of 1,882 shares made by Yezan Munther Haddadin .
In summary, during the past 3 months, insiders sold 0 shares of Outlook Therapeutics Inc (OTLK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 26,000 shares of Outlook Therapeutics Inc (OTLK) were sold and 5,006 shares were bought by its insiders, resulting in a net sale of 20,994 shares.
Outlook Therapeutics Inc (OTLK)'s detailed insider trading history can be found in Insider Trading Tracker table.
Outlook Therapeutics Inc Insider Transactions
Scott A. Gangloff Mailing Address
Above is the net worth, insider trading, and ownership report for Scott A. Gangloff. You might contact Scott A. Gangloff via mailing address: C/o Oncobiologics, Inc., 7 Clarke Drive, Cranbury Nj 08512.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
